Health Care: Drugs

Novavax Inc (NVAX: NASDAQ)

$1.18 n/a | n/a%
06/23/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 15.35M 36.25M 30.66M 20.91M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 15.35M 36.25M 30.66M 20.91M
Selling, General, and Administrative Expenses 46.53M 30.84M 19.93M 14.82M
Research & Development 237.94M 162.64M 94.42M 58.53M
Operating Income before D & A (EBITDA) -269.11M -157.24M -83.69M -52.43M
Depreciation & Amortization 10.07M 7.20M 4.84M 3.10M
Interest Income 0.00 0.00 0.00 187.00K
Other Income - Net 2.11M 540.00K 901.00K 449.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -277.07M -163.90M -87.63M -54.90M
Interest Expense 12.96M 241.00K 157.00K 160.00K
Pre-Tax Income -290.03M -164.14M -87.79M -55.06M
Income Taxes 0.00 0.00 0.00 25.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -279.97M -156.94M -82.95M -51.98M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -279.97M -156.94M -82.95M -51.98M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -279.97M -156.94M -82.95M -51.98M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-279.97M -156.94M -82.95M -51.98M
Preferred Dividends
Net Income Available To Common -279.97M -156.94M -82.95M -51.98M
Basic EPS from Continuing Ops. -1.03 -0.60 -0.37 -0.31
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.03 -0.60 -0.37 -0.31
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.03 -0.60 -0.37 -0.31
Basic Normalized Net Income/Share -1.03 -0.60 -0.37 -0.31
EPS fr Continuing Ops. -1.03 -0.60 -0.37 -0.31
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.03 -0.60 -0.37 -0.31
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.03 -0.60 -0.37 -0.31
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.03 -0.60 -0.37 -0.31
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with NVAX

Latest NVAX Headlines from TheStreet

More Financial News for NVAX

Press Releases for NVAX

See All Press Releases

Partner Headlines for NVAX

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter